Cargando…
A multi-centre phase IIa clinical study of predictive testing for preeclampsia: improved pregnancy outcomes via early detection (IMPROvED)
BACKGROUND: 5% of first time pregnancies are complicated by pre-eclampsia, the leading cause of maternal death in Europe. No clinically useful screening test exists; consequentially clinicians are unable to offer targeted surveillance or preventative strategies. IMPROvED Consortium members have pion...
Autores principales: | Navaratnam, Kate, Alfirevic, Zarko, Baker, Philip N, Gluud, Christian, Grüttner, Berthold, Kublickiene, Karolina, Zeeman, Gerda, Kenny, Louise C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4029471/ https://www.ncbi.nlm.nih.gov/pubmed/24314209 http://dx.doi.org/10.1186/1471-2393-13-226 |
Ejemplares similares
-
Early Pregnancy Biomarkers in Pre-Eclampsia: A Systematic Review and Meta-Analysis
por: Wu, Pensée, et al.
Publicado: (2015) -
Preeclampsia and risk of end stage kidney disease: A Swedish nationwide cohort study
por: Khashan, Ali S., et al.
Publicado: (2019) -
Correction: Preeclampsia and risk of end stage kidney disease: A Swedish nationwide cohort study
por: Khashan, Ali S., et al.
Publicado: (2019) -
STRIDER: Sildenafil therapy in dismal prognosis early-onset intrauterine growth restriction – a protocol for a systematic review with individual participant data and aggregate data meta-analysis and trial sequential analysis
por: Ganzevoort, Wessel, et al.
Publicado: (2014) -
Low dose aspirin and pregnancy: how important is aspirin resistance?
por: Navaratnam, K, et al.
Publicado: (2016)